Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000670706 | SCV000795597 | uncertain significance | GRACILE syndrome | 2017-11-09 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000778591 | SCV000914898 | uncertain significance | Mitochondrial complex III deficiency nuclear type 1 | 2017-05-22 | criteria provided, single submitter | clinical testing | The BCS1L c.217C>T (p.Arg73Cys) variant has been reported in two studies in the same individual with mitochondrial respiratory chain complex III deficiency in a compound heterozygous state with another missense variant (Fernandez-Vizarra et al. 2007; Invernizzi et al. 2012). The p.Arg73Cys variant was absent from 210 control alleles, but is reported at a frequency of 0.00315 in the Ashkenazi Jewish population of the Genome Aggregation Database. The Arg73 residue is conserved across multiple species. Patient fibroblasts showed 30% residual enzyme activity and 50% maximum respiration rate compared to wild type (Invernizzi et al. 2012). Growth complementation studies in yeast showed that the p.Arg73Cys variant alone was insufficient to cause a growth defect, but in the presence of the other missense variant from the compound heterozygous patient, growth was significantly reduced compared to wild type. A similar result was obtained looking at the mitochondrial cytochrome profile and respiration activity (Fernandez-Vizarra et al. 2007; Invernizzi et al. 2012). The evidence for this variant is limited. The p.Arg73Cys variant is therefore classified as a variant of unknown significance but suspicious for pathogenicity for mitochondrial respiratory chain complex III deficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. |
Ce |
RCV001171821 | SCV001334690 | pathogenic | not provided | 2020-03-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001171821 | SCV001689654 | likely benign | not provided | 2021-11-13 | criteria provided, single submitter | clinical testing |